BIONET THERAPEUTICS CORP

Overview

BIONET THERAPEUTICS CORP is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering EXOSOMES DERIVED FROM UMBILICAL CORD MESENCHYMAL STEM CELLS (UCMSC EXOSOMES).

API / Drug Master Files

BIONET THERAPEUTICS CORP holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EXOSOMES DERIVED FROM UMBILICAL CORD MESENCHYMAL STEM CELLS (UCMSC EXOSOMES)Active2025-06-16

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BIONET THERAPEUTICS CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.